About

Bernardo Rocco is a prominent urological surgeon and researcher whose work sits at the intersection of robotic surgery, prostate cancer management, and surgical innovation. Based at a high-volume robotic surgery center, Rocco has made significant contributions to the field of robot-assisted radical prostatectomy (RARP), exploring both clinical outcomes and cutting-edge technological advances. His highly cited 2021 study linking Oncotype DX genomic profiling to adverse tumor pathology (38 citations) reflects his commitment to precision oncology, while his work on puboprostatic ligament reconstruction has helped shape best practices for improving post-surgical urinary continence. Rocco has been a pioneer in evaluating next-generation robotic platforms, including Hugo RAS and Versius CMR, producing some of the earliest comparative cost analyses and clinical outcome data for these emerging systems. His 2019 augmented reality RARP case — integrating 3D MRI reconstruction with predictive cancer modeling — exemplifies his appetite for surgical innovation. From navigating prostate cancer care during COVID-19 to co-authoring telesurgery guidelines for the Society of Robotic Surgery, Rocco's research consistently bridges technical advancement with real-world clinical impact, making him an influential voice in contemporary robotic urology.

Research Focus

Key Achievements

8
H-Index
18
Papers
187
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Association Between Oncotype DX Genomic Prostate Score and Adverse Tumor Pathology After Radical Prostatectomy
38 citations · 2021
📈 Most Prolific Year: 2025 (6 Papers)
🤝 Key Collaborators: 169
🏛 Institutions: University of Modena and Reggio Emilia, University of Milan, Ospedale San Paolo, Agostino Gemelli University Polyclinic, Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago